Dear Friends & Colleagues,

​

We invite you to join us for the 7th Annual Heart in Diabetes (HiD) CME Conference, a unique and exciting multidisciplinary program: Where the Heart, Kidney, and Diabetes Meet in Clinical Practice.

​

For half a decade, the annual Heart in Diabetes (HID) Congress has brought together internationally known experts with practicing clinicians to share knowledge and best practices for managing patients with cardio-renal-metabolic disorders. This one-of-a-kind meeting has become an important venue where clinicians from multiple specialties work together to improve care for patients with diabetes, cardiovascular disease (CVD), chronic kidney disease (CKD), heart failure (HF), and related conditions. Until recently, these conditions were treated as separate diseases and largely managed by different specialists with different clinical priorities and goals. The HID platform facilitates an approach based on the common pathways underlying cardiorenal and metabolic diseases. To continue to promote synergy in patient care, the cardio-renal-metabolic community will gather once again at the 7th Annual Heart in Diabetes. The meeting will take place June 9-11, 2023, in Philadelphia, PA.

 

The 6th Annual Heart in Diabetes conference was live in-person and online followed by 90 days of on-demand access. Each year, the HiD Conference is a rousing success, with progressive growth in attendance and impressive conference evaluations, with over 2,400 registrations from 76 countries. The evaluations have been remarkable, rating the overall quality of the meeting at 98%. Ninety-eight percent of participants stated that they will recommend the meeting to others and will return the following year.  

​

The 6th HiD Luminary in Cardiometabolic Medicine Award was presented to Dr. Ralph DeFronzo. Key sessions included COVID-19, Diabetes, and the Heart, Guidelines Update and the DCRM Multispecialty Practice Recommendations for Diabetes and Cardiorenal and Metabolic Diseases, Lipids—Current and Emerging Therapies, Heart Disease in Women, Stroke, and Dementia in Diabetes, Management of Diabetes Circa 2022, CAC Scoring—Clinical Implications and Utility, Contemporary Approach to Heart Failure, Prevention and Treatment of CKD, Digital Health and Technology, Fatty Liver and the Heart, and more. Speakers will address clinical implications, and all sessions were concluded with panel discussions and an open forum for audience questions. There was a robust opportunity for the audience to interact with the faculty.

Another unique feature was a daily summary session with a panel discussion and Q&A with internationally celebrated faculty. The meeting also featured posters and oral abstract presentations from scientists and researchers around the world, as well as several non-CME, industry-supported presentations.

​

Abstracts will be published in the American Heart Journal
(www.journals.elsevier.com/american-heart-journal, Editor-in-Chief: Daniel Mark, MD, MPH).
 

If you are a cardiologist, endocrinologist, nephrologist, diabetologist, lipidologist, internist, or clinician with an interest in the science of the Heart in Diabetes, this meeting is for you! We invite you to join us in this exciting endeavor.

 

We look forward to seeing you in Philadelphia, PA in June 2023 for our 7th encounter!

​

Thank you,